Tonix Pharmaceuticals (TNXP) SEC Filings & 10K Form

$0.20
+0.02 (+11.29%)
(As of 05/17/2024 ET)

Recent Tonix Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/13/2024
3:56 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
3:49 PM
Tonix Pharmaceuticals (Filer)
Form ARS
04/15/2024
3:38 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
04/05/2024
3:47 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
03/29/2024
4:28 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
03/29/2024
4:16 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
8:03 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
8:23 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
8:48 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
7:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:01 PM
LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4/A
03/06/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
4:05 PM
SULLIVAN GREGORY M (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:06 PM
MORRIS JESSICA EDGAR (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:07 PM
SAENGER BRADLEY (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:08 PM
LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
7:07 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
6:00 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:31 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
3:53 PM
Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G
01/08/2024
4:07 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
3:33 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
01/02/2024
3:15 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:04 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
12/26/2023
4:25 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
12/21/2023
4:28 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
12/21/2023
4:15 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
12/21/2023
4:04 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
9:31 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
6:00 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
4:14 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
6:10 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Buy this small stock before coming AI Tidal Wave (Ad)

The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.

Get the name and ticker symbol for free - just click here.
11/09/2023
3:23 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:27 PM
Tonix Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
6:49 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2023
6:17 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
3:53 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
10/20/2023
4:07 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
3:32 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
3:15 PM
Tonix Pharmaceuticals (Filer)
Form 424B4
09/29/2023
3:16 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
7:35 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:36 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
7:28 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
8:15 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
7:31 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
6:07 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
6:51 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
6:15 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
7:35 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
6:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
7:30 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
6:30 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2023
4:24 PM
Tonix Pharmaceuticals (Filer)
Form 8-K/A
07/17/2023
6:12 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
4:05 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
7:17 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
4:12 PM
Tonix Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/15/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
4:29 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2023
6:01 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
6:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TNXP) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners